IN8bio raises ~$1.9M via warrant exercises/exchanges at reduced prices; Series B warrant strike cut to $0.45

IN8BIO, INC.

Warrant exercises for 7,178,934 Series A and 2,142,147 Series B shares at $0.1844 (insiders) or $0.1784 (others) per share.
Warrant exchanges: 656,208 Series A and 574,241 Series B surrendered for pre-funded warrants at $0.0001 exercise price.
Total expected gross proceeds of ~$1.9 million from the transactions.
Series B warrant exercise price amended from $1.50 to $0.45 for holders not participating in exercises.
Transactions must close by May 2, 2025; warrants unexercised by then will terminate.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.